Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Envoy Medical (COCH) Profit After Tax (2022 - 2025)

Envoy Medical's Profit After Tax history spans 4 years, with the latest figure at -$6.6 million for Q4 2025.

  • Quarterly results put Profit After Tax at -$6.6 million for Q4 2025, down 42.62% from a year ago — trailing twelve months through Dec 2025 was -$23.8 million (down 14.24% YoY), and the annual figure for FY2025 was -$23.8 million, down 14.24%.
  • Profit After Tax for Q4 2025 was -$6.6 million at Envoy Medical, down from -$6.5 million in the prior quarter.
  • In the past five years, Profit After Tax ranged from a high of $1.6 million in Q3 2023 to a low of -$13.3 million in Q2 2023.
  • The 4-year median for Profit After Tax is -$5.3 million (2025), against an average of -$5.6 million.
  • Peak annual rise in Profit After Tax hit 216.73% in 2023, while the deepest fall reached 979.05% in 2023.
  • Year by year, Profit After Tax stood at -$11.5 million in 2022, then skyrocketed by 57.35% to -$4.9 million in 2023, then increased by 5.66% to -$4.6 million in 2024, then tumbled by 42.62% to -$6.6 million in 2025.
  • According to Business Quant data, Profit After Tax over the past three periods came in at -$6.6 million, -$6.5 million, and -$5.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.